Patent · US Active

PQS and its conjugates as adjuvants and their uses in pharmaceutical compositions

US8257734B2 · kind B2 · utility

1Cited by

1References

13Claims

0Family size

Assignee

Helmholtz-Zentrum Für Infektionsforschung GmbH · DE

Inventors

Thomas Ebensen · Hannover, DE
Michael Morr · Wolfenbüttel, DE
Carlos Guzman · Wolfenbüttel, DE

Key dates

Filing date	Nov 8, 2006
Grant date	Sep 4, 2012
Priority date	—
Expiry date	Jun 29, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to new adjuvants and the uses in pharmaceutical compositions, like in vaccines. In particular, the present invention provides new compounds useful as adjuvants and/or immunomodulators for prophylactic and/or therapeutic vaccination in the treatment of infectious diseases, inflammatory diseases, autoimmune diseases, tumors, allergies as well as for the control of fertility in human or animal populations. The compounds are particularly useful not only as systemic, but preferably as mucosal adjuvants. In addition, the invention relates to its uses as active ingredients in pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.